Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America

Detalles Bibliográficos
Autores principales: Garneau, Alexandre P., Haydock, Ludwig, Tremblay, Laurence E., Isenring, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900069/
https://www.ncbi.nlm.nih.gov/pubmed/33392635
http://dx.doi.org/10.1007/s00109-020-02030-6
_version_ 1783654144586809344
author Garneau, Alexandre P.
Haydock, Ludwig
Tremblay, Laurence E.
Isenring, Paul
author_facet Garneau, Alexandre P.
Haydock, Ludwig
Tremblay, Laurence E.
Isenring, Paul
author_sort Garneau, Alexandre P.
collection PubMed
description
format Online
Article
Text
id pubmed-7900069
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-79000692021-03-05 Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America Garneau, Alexandre P. Haydock, Ludwig Tremblay, Laurence E. Isenring, Paul J Mol Med (Berl) Commentary Springer Berlin Heidelberg 2021-01-03 2021 /pmc/articles/PMC7900069/ /pubmed/33392635 http://dx.doi.org/10.1007/s00109-020-02030-6 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Commentary
Garneau, Alexandre P.
Haydock, Ludwig
Tremblay, Laurence E.
Isenring, Paul
Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
title Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
title_full Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
title_fullStr Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
title_full_unstemmed Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
title_short Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
title_sort somatic non-cancerous pik3ca-related overgrowth syndrome treated with alpelisib in north america
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900069/
https://www.ncbi.nlm.nih.gov/pubmed/33392635
http://dx.doi.org/10.1007/s00109-020-02030-6
work_keys_str_mv AT garneaualexandrep somaticnoncancerouspik3carelatedovergrowthsyndrometreatedwithalpelisibinnorthamerica
AT haydockludwig somaticnoncancerouspik3carelatedovergrowthsyndrometreatedwithalpelisibinnorthamerica
AT tremblaylaurencee somaticnoncancerouspik3carelatedovergrowthsyndrometreatedwithalpelisibinnorthamerica
AT isenringpaul somaticnoncancerouspik3carelatedovergrowthsyndrometreatedwithalpelisibinnorthamerica

Ejemplares similares